To evaluate the safety of benzodiazepines and opioids in patients with very severe chronic obstructive pulmonary disease (COPD)
Previous studies have shown that opioids can reduce chronic breathlessness in advanced disease. Howe...
Previous studies have shown that opioids can reduce chronic breathlessness in advanced disease. Howe...
Chronic use of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD...
Objective To evaluate the safety of benzodiazepines and opioids in patients with very severe chronic...
Objective: To evaluate the safety of benzodiazepines and opioids in patients with very severe chroni...
Breathlessness is a key symptom in chronic obstructive pulmonary disease (COPD) with prognostic impl...
Benzodiazepines, available clinically for almost six decades, are still one of the most widely presc...
Background: Despite evidence that opioids might relieve chronic breathlessness, physicians may still...
Copyright ©ERS 2018 Safety concerns are a barrier to prescribing benzodiazepines (BDZs) and opioids ...
Background: The common comorbidities associated with COPD include, among others, anxiety, depression...
9 Murciano D, Armengaud MH, Cramer PH, et al. Acute effects of zolpidem, triazolam and flunitrazepam...
International audienceThere is still debate as to the safety of non-palliative opioid administration...
Xiao-Min Lu,* Ji-Ping Zhu,* Xian-Mei Zhou Department of Respiratory Medicine, Affiliated Jiangsu Pr...
Background: Breathlessness at rest or on minimal exertion despite optimal treatment of underlying ca...
Background: Breathlessness at rest or on minimal exertion despite optimal treatment of underlying ca...
Previous studies have shown that opioids can reduce chronic breathlessness in advanced disease. Howe...
Previous studies have shown that opioids can reduce chronic breathlessness in advanced disease. Howe...
Chronic use of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD...
Objective To evaluate the safety of benzodiazepines and opioids in patients with very severe chronic...
Objective: To evaluate the safety of benzodiazepines and opioids in patients with very severe chroni...
Breathlessness is a key symptom in chronic obstructive pulmonary disease (COPD) with prognostic impl...
Benzodiazepines, available clinically for almost six decades, are still one of the most widely presc...
Background: Despite evidence that opioids might relieve chronic breathlessness, physicians may still...
Copyright ©ERS 2018 Safety concerns are a barrier to prescribing benzodiazepines (BDZs) and opioids ...
Background: The common comorbidities associated with COPD include, among others, anxiety, depression...
9 Murciano D, Armengaud MH, Cramer PH, et al. Acute effects of zolpidem, triazolam and flunitrazepam...
International audienceThere is still debate as to the safety of non-palliative opioid administration...
Xiao-Min Lu,* Ji-Ping Zhu,* Xian-Mei Zhou Department of Respiratory Medicine, Affiliated Jiangsu Pr...
Background: Breathlessness at rest or on minimal exertion despite optimal treatment of underlying ca...
Background: Breathlessness at rest or on minimal exertion despite optimal treatment of underlying ca...
Previous studies have shown that opioids can reduce chronic breathlessness in advanced disease. Howe...
Previous studies have shown that opioids can reduce chronic breathlessness in advanced disease. Howe...
Chronic use of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD...
DOI
Add to ORKG